Northern Trust’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3M Buy
577,267
+27,269
+5% +$743K ﹤0.01% 1726
2025
Q4
$14.9M Sell
549,998
-45,387
-8% -$1.2M ﹤0.01% 1862
2025
Q3
$15.4M Buy
595,385
+19,510
+3% +$452K ﹤0.01% 1864
2025
Q2
$11.7M Sell
575,875
-1,486
-0.3% -$28.9K ﹤0.01% 1969
2025
Q1
$10.5M Sell
577,361
-20,244
-3% -$452K ﹤0.01% 2012
2024
Q4
$15.1M Buy
597,605
+34,885
+6% +$948K ﹤0.01% 1878
2024
Q3
$19.1M Buy
562,720
+17,126
+3% +$653K ﹤0.01% 1646
2024
Q2
$20.2M Sell
545,594
-8,267
-1% -$312K ﹤0.01% 1556
2024
Q1
$23.2M Buy
553,861
+109,056
+25% +$4.48M ﹤0.01% 1491
2023
Q4
$17.6M Sell
444,805
-29,115
-6% -$856K ﹤0.01% 1702
2023
Q3
$13M Sell
473,920
-13,832
-3% -$434K ﹤0.01% 1822
2023
Q2
$16.5M Buy
487,752
+7,199
+1% +$243K ﹤0.01% 1720
2023
Q1
$17.3M Buy
480,553
+45,941
+11% +$1.98M ﹤0.01% 1643
2022
Q4
$19.4M Buy
434,612
+12,371
+3% +$442K ﹤0.01% 1549
2022
Q3
$11.9M Sell
422,241
-1,426
-0.3% -$43.7K ﹤0.01% 1861
2022
Q2
$11.4M Sell
423,667
-15,867
-4% -$461K ﹤0.01% 1928
2022
Q1
$15M Sell
439,534
-24,630
-5% -$787K ﹤0.01% 1885
2021
Q4
$17.9M Buy
464,164
+5,051
+1% +$220K ﹤0.01% 1852
2021
Q3
$24.8M Buy
459,113
+46,850
+11% +$2.2M ﹤0.01% 1646
2021
Q2
$13.8M Buy
412,263
+305,057
+285% +$8.37M ﹤0.01% 2157
2021
Q1
$2.21M Buy
107,206
+12,217
+13% +$281K ﹤0.01% 3193
2020
Q4
$1.66M Buy
94,989
+6,644
+8% +$120K ﹤0.01% 3275
2020
Q3
$1.31M Buy
88,345
+31,045
+54% +$364K ﹤0.01% 3262
2020
Q2
$744K Buy
57,300
+23,040
+67% +$102K ﹤0.01% 3456
2020
Q1
$57K Sell
34,260
-321
-0.9% -$725 ﹤0.01% 3931
2019
Q4
$78K Buy
34,581
+5,154
+18% +$12K ﹤0.01% 3977
2019
Q3
$63K Buy
29,427
+529
+2% +$1.22K ﹤0.01% 4018
2019
Q2
$77K Buy
28,898
+688
+2% +$2.34K ﹤0.01% 4011
2019
Q1
$139K Buy
28,210
+3,201
+13% +$16.8K ﹤0.01% 3846
2018
Q4
$74K Sell
25,009
-20,651
-45% -$101K ﹤0.01% 3980
2018
Q3
$309K Sell
45,660
-23,925
-34% -$168K ﹤0.01% 3750
2018
Q2
$526K Sell
69,585
-74,212
-52% -$992K ﹤0.01% 3588
2018
Q1
$5.03M Buy
143,797
+2,462
+2% +$95.4K ﹤0.01% 2588
2017
Q4
$6.02M Buy
141,335
+4,378
+3% +$188K ﹤0.01% 2492
2017
Q3
$5.88M Buy
136,957
+2,237
+2% +$83.9K ﹤0.01% 2531
2017
Q2
$4.99M Buy
134,720
+14,644
+12% +$648K ﹤0.01% 2644
2017
Q1
$6.5M Buy
120,076
+711
+0.6% +$37K ﹤0.01% 2391
2016
Q4
$6.34M Buy
119,365
+6,884
+6% +$392K ﹤0.01% 2388
2016
Q3
$6.82M Buy
112,481
+23,077
+26% +$1.44M ﹤0.01% 2317
2016
Q2
$5.89M Buy
89,404
+15,691
+21% +$996K ﹤0.01% 2354
2016
Q1
$4.19M Buy
73,713
+241
+0.3% +$27.1K ﹤0.01% 2519
2015
Q4
$17.3M Buy
73,472
+1,069
+1% +$233K 0.01% 1609
2015
Q3
$11.4M Buy
72,403
+625
+0.9% +$177K ﹤0.01% 1900
2015
Q2
$27.2M Buy
71,778
+3,265
+5% +$1.3M 0.01% 1329
2015
Q1
$28.6M Buy
68,513
+2,307
+3% +$825K 0.01% 1299
2014
Q4
$18.1M Sell
66,206
-1,386
-2% -$345K 0.01% 1612
2014
Q3
$13.1M Sell
67,592
-4,175
-6% -$910K ﹤0.01% 1836
2014
Q2
$17.6M Sell
71,767
-6,077
-8% -$1.37M 0.01% 1613
2014
Q1
$20.6M Sell
77,844
-7,250
-9% -$2.78M 0.01% 1547
2013
Q4
$30.9M Buy
85,094
+8,949
+12% +$3.45M 0.01% 1150
2013
Q3
$40.5M Sell
76,145
-772
-1% -$265K 0.01% 862
2013
Q2
$18M Buy
+76,917
New +$15.1M 0.01% 1460

Other funds holding CLDX